Yeo RM - Search Results

1

Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J, Tan TW, Fong KW, Chua ET, Wee JT. Tham IW, et al. Among authors: yeo rm. Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1481-6. doi: 10.1016/j.ijrobp.2009.01.018. Epub 2009 Apr 20. Int J Radiat Oncol Biol Phys. 2009. PMID: 19386431

2

FIGO stage 1B2 cervical carcinoma--the KK Women's and Children's Hospital experience.

Han CC, Low JJ, Yeo R, Lee KM, Khoo-Tan HS, Tay EH, Yam KL, Ho TH. Han CC, et al. Ann Acad Med Singap. 2003 Sep;32(5):665-9. Ann Acad Med Singap. 2003. PMID: 14626799

3

Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.

Yeo R, Fong KW, Hee SW, Chua ET, Tan T, Wee J. Yeo R, et al. Head Neck. 2009 Dec;31(12):1610-8. doi: 10.1002/hed.21130. Head Neck. 2009. PMID: 19536853

4

Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.

Teh J, Yap SP, Tham I, Sethi VK, Chua EJ, Yeo R, Ho TH, Tay EH, Chia YN, Soh LT, Khoo-Tan HS. Teh J, et al. Int J Gynecol Cancer. 2010 Apr;20(3):428-33. doi: 10.1111/IGC.0b013e3181d4a0d1. Int J Gynecol Cancer. 2010. PMID: 20375809

5

Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK/T-cell lymphomas)?

Wee J, Nei WL, Yeoh KW, Yeo RM, Loong SL, Qian CN. Wee J, et al. Among authors: yeo rm. Med Hypotheses. 2012 Dec;79(6):833-42. doi: 10.1016/j.mehy.2012.09.003. Epub 2012 Oct 15. Med Hypotheses. 2012. PMID: 23079399

6

A Prospective Randomized Controlled Trial to Compare the Use of Conventional Dark-Ink Tattoo and Ultraviolet-Ink Tattoo for Patients Undergoing Breast Radiation Therapy.

Lim LH, Pang EPP, Sultana R, Kusumawidjaja G, Wong RX, Yeo RMC, Ho BS, Ng WL, Lim FLWT, Chua ET, Sim AYF, Wong FY. Lim LH, et al. Among authors: yeo rmc. Pract Radiat Oncol. 2021 Nov-Dec;11(6):463-469. doi: 10.1016/j.prro.2021.08.001. Epub 2021 Aug 17. Pract Radiat Oncol. 2021. PMID: 34411756 Clinical Trial.

7

Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer.

Tay WL, Yip GW, Tan PH, Matsumoto K, Yeo R, Ng TP, Kumar SD, Tsujimoto M, Bay BH. Tay WL, et al. Mod Pathol. 2009 Feb;22(2):282-90. doi: 10.1038/modpathol.2008.181. Epub 2008 Oct 31. Mod Pathol. 2009. PMID: 18978732 Free article.

8

Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.

Kumar VJ, Nin CY, Kuei LY, Tan KH, Yeo R, Lam PY. Kumar VJ, et al. Int J Gynecol Cancer. 2010 May;20(4):564-9. doi: 10.1111/IGC.0b013e3181d7ce94. Int J Gynecol Cancer. 2010. PMID: 20686374

9

Cancer and radiation therapy: current advances and future directions.

Baskar R, Lee KA, Yeo R, Yeoh KW. Baskar R, et al. Int J Med Sci. 2012;9(3):193-9. doi: 10.7150/ijms.3635. Epub 2012 Feb 27. Int J Med Sci. 2012. PMID: 22408567 Free PMC article. Review.

10

Biological response of cancer cells to radiation treatment.

Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW. Baskar R, et al. Front Mol Biosci. 2014 Nov 17;1:24. doi: 10.3389/fmolb.2014.00024. eCollection 2014. Front Mol Biosci. 2014. PMID: 25988165 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page